[go: up one dir, main page]

FI952119L - Stable freeze-dried formulation containing protein and test kit - Google Patents

Stable freeze-dried formulation containing protein and test kit Download PDF

Info

Publication number
FI952119L
FI952119L FI952119A FI952119A FI952119L FI 952119 L FI952119 L FI 952119L FI 952119 A FI952119 A FI 952119A FI 952119 A FI952119 A FI 952119A FI 952119 L FI952119 L FI 952119L
Authority
FI
Finland
Prior art keywords
test kit
formulation containing
containing protein
dried formulation
stable freeze
Prior art date
Application number
FI952119A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI952119A0 (en
FI117321B (en
Inventor
Alain Bayol
Thierry Breul
Patrice Dupin
Philippe Faure
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of FI952119A0 publication Critical patent/FI952119A0/en
Publication of FI952119L publication Critical patent/FI952119L/en
Application granted granted Critical
Publication of FI117321B publication Critical patent/FI117321B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI952119A 1994-05-04 1995-05-03 Stable freeze-dried compost containing a protein, and test packaging FI117321B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9405486 1994-05-04
FR9405486A FR2719479B1 (en) 1994-05-04 1994-05-04 Stable lyophilized formulation comprising a protein: assay kit.

Publications (3)

Publication Number Publication Date
FI952119A0 FI952119A0 (en) 1995-05-03
FI952119L true FI952119L (en) 1995-11-05
FI117321B FI117321B (en) 2006-09-15

Family

ID=9462880

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952119A FI117321B (en) 1994-05-04 1995-05-03 Stable freeze-dried compost containing a protein, and test packaging

Country Status (25)

Country Link
US (1) US5763409A (en)
EP (1) EP0682944B1 (en)
JP (1) JP2948125B2 (en)
KR (1) KR100273053B1 (en)
CN (1) CN1088583C (en)
AT (1) ATE178484T1 (en)
AU (1) AU694763B2 (en)
CA (1) CA2148537C (en)
CZ (1) CZ286195B6 (en)
DE (1) DE69508837T2 (en)
DK (1) DK0682944T3 (en)
ES (1) ES2131781T3 (en)
FI (1) FI117321B (en)
FR (1) FR2719479B1 (en)
GR (1) GR3030146T3 (en)
HU (1) HU220220B (en)
IL (1) IL113578A (en)
MX (1) MX9502034A (en)
NO (1) NO320364B1 (en)
NZ (1) NZ272045A (en)
PL (1) PL179240B1 (en)
RU (1) RU2136306C1 (en)
SI (1) SI0682944T1 (en)
TW (1) TW397687B (en)
ZA (1) ZA953596B (en)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267958B1 (en) * 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
US6685940B2 (en) * 1995-07-27 2004-02-03 Genentech, Inc. Protein formulation
MX9800684A (en) * 1995-07-27 1998-04-30 Genentech Inc Stabile isotonic lyophilized protein formulation.
DE19539574A1 (en) * 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Preparations and processes for stabilizing biological materials by means of drying processes without freezing
FR2740686B1 (en) * 1995-11-03 1998-01-16 Sanofi Sa STABLE LYOPHILIZED PHARMACEUTICAL FORMULATION
EP0852951A1 (en) * 1996-11-19 1998-07-15 Roche Diagnostics GmbH Stable lyophilized monoclonal or polyclonal antibodies containing pharmaceuticals
FR2768341B1 (en) 1997-09-18 2000-04-14 Lab Francais Du Fractionnement LYOPHILISABLE PLACEBO PHARMACEUTICAL COMPOSITION FOR IMITATING A MEDICAMENT, IN PARTICULAR BASED ON PROTEINS OR POLYPEPTIDES
EP0913178A1 (en) * 1997-11-03 1999-05-06 Boehringer Mannheim Gmbh Process for the manufacture of dry, amorphous products comprising biologically active material by means of convection drying and products obtainable by the process
EP0913177A1 (en) 1997-11-03 1999-05-06 Roche Diagnostics GmbH Process for producing dry, amorphous products comprising biological active materials by means of convection drying technique, especially spray drying
EP1071465A1 (en) * 1998-03-18 2001-01-31 Ronai, Peter Amorphous glasses for stabilising sensitive products
EP1820516B1 (en) 1999-02-22 2013-07-24 University of Connecticut Novel albumin-free factor VIII formulations
DE10085144T1 (en) * 1999-10-28 2003-04-24 Inst Neftechimicheskogo Sintez Polypeptidkomposition
US6653062B1 (en) 2000-07-26 2003-11-25 Wisconsin Alumni Research Foundation Preservation and storage medium for biological materials
JP4129178B2 (en) 2000-11-07 2008-08-06 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド Stabilized interferon composition
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
RU2279292C2 (en) * 2001-10-24 2006-07-10 Пари Гмбх Set for pharmaceutical composition preparing
CN102353569A (en) 2002-05-13 2012-02-15 贝克顿·迪金森公司 Protease inhibitor sample collection system
US6803046B2 (en) * 2002-08-16 2004-10-12 Bracco International B.V. Sincalide formulations
DE602004015725D1 (en) * 2003-01-08 2008-09-25 Novartis Vaccines & Diagnostic STABILIZED LYOPHILIZED PREPARATIONS WITH TISSUE FACTOR INHIBITOR (TFPI) OR VARIATIONS OF TISSUE FACTOR INHIBITOR
GB0304636D0 (en) * 2003-02-28 2003-04-02 Britannia Pharmaceuticals Ltd Pharmaceutical composition for nasal delivery
DE10333317A1 (en) * 2003-07-22 2005-02-17 Biotecon Therapeutics Gmbh Formulation for protein medicines without the addition of human serum albumin (HSA)
GB0404586D0 (en) * 2004-03-01 2004-04-07 Britannia Pharmaceuticals Ltd Improvements in or relating to organic materials
US11229746B2 (en) 2006-06-22 2022-01-25 Excelsior Medical Corporation Antiseptic cap
AR063606A1 (en) 2006-11-07 2009-02-04 Acambis Inc VACCINE STABILIZATION THROUGH LIOFILIZATION
CA2692165A1 (en) * 2007-06-25 2008-12-31 Amgen Inc. Compositions of specific binding agents to hepatocyte growth factor
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
US9078992B2 (en) 2008-10-27 2015-07-14 Pursuit Vascular, Inc. Medical device for applying antimicrobial to proximal end of catheter
US20100168018A1 (en) 2008-11-07 2010-07-01 Baxter International Inc. Factor viii formulations
CN104398471A (en) * 2008-11-28 2015-03-11 Abbvie公司 Stable antibody compositions and methods for stabilizing same
PL2496246T3 (en) * 2009-11-03 2018-09-28 Grifols Therapeutics Llc Composition, method, and kit for alpha-1 proteinase inhibitor
EP3257525A3 (en) * 2009-12-22 2018-02-28 Celldex Therapeutics, Inc. Vaccine compositions
RU2448156C1 (en) * 2011-03-17 2012-04-20 Эспосито Трейдинг Лтд Method of producing lyophilised substance
RU2448158C1 (en) * 2011-03-24 2012-04-20 Эспосито Трейдинг Лтд Method for preparing preparation fortelysin showing fibrinolytic properties, and its application for treating myocardial infraction
US10166381B2 (en) 2011-05-23 2019-01-01 Excelsior Medical Corporation Antiseptic cap
EP2731658B1 (en) 2011-07-12 2020-04-01 Pursuit Vascular, Inc. Device for delivery of antimicrobial agent into trans-dermal catheter
WO2013078130A1 (en) * 2011-11-22 2013-05-30 Siemens Healthcare Diagnostics Inc. Devices containing dried reagents for reconstitution as calibration and/or quality control solutions, and methods of production and use thereof
US20140017318A1 (en) * 2012-07-10 2014-01-16 Kevin O'Connell Method to produce a medicinal product comprising a biologically active protein and the resulting product
US9314519B2 (en) 2012-08-21 2016-04-19 Intervet Inc. Liquid stable virus vaccines
US9393298B2 (en) 2013-03-15 2016-07-19 Intervet Inc. Liquid stable bovine virus vaccines
US9480739B2 (en) 2013-03-15 2016-11-01 Intervet Inc. Bovine virus vaccines that are liquid stable
AR097762A1 (en) 2013-09-27 2016-04-13 Intervet Int Bv DRY FORMULATIONS OF VACCINES THAT ARE STABLE AT ENVIRONMENTAL TEMPERATURE
AU2014329003A1 (en) * 2013-09-27 2016-05-12 Hanmi Pharm. Co., Ltd. A formulation of long-acting human growth hormone conjugate
AR099470A1 (en) 2014-02-17 2016-07-27 Intervet Int Bv LIQUID CORRAL BIRD VIRUS VACCINES
TWI670085B (en) 2014-02-19 2019-09-01 荷蘭商英特威國際公司 Swine virus vaccines that are liquid stable
EP3137122B1 (en) 2014-05-02 2019-09-04 Excelsior Medical Corporation Strip package for antiseptic cap
CA2982456A1 (en) 2015-05-08 2016-11-17 Icu Medical, Inc. Medical connectors configured to receive emitters of therapeutic agents
CA2989110A1 (en) 2015-06-11 2016-12-15 Attwill Medical Solutions Inc. Medical devices, systems, and methods utilizing antithrombin-heparin compositions
US10744316B2 (en) 2016-10-14 2020-08-18 Icu Medical, Inc. Sanitizing caps for medical connectors
WO2018204206A2 (en) 2017-05-01 2018-11-08 Icu Medical, Inc. Medical fluid connectors and methods for providing additives in medical fluid lines
US11110063B2 (en) 2017-08-25 2021-09-07 MAIA Pharmaceuticals, Inc. Storage stable sincalide formulations
US11541220B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Needleless connector with antimicrobial properties
US11517732B2 (en) 2018-11-07 2022-12-06 Icu Medical, Inc. Syringe with antimicrobial properties
US11541221B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Tubing set with antimicrobial properties
US11534595B2 (en) 2018-11-07 2022-12-27 Icu Medical, Inc. Device for delivering an antimicrobial composition into an infusion device
US11400195B2 (en) 2018-11-07 2022-08-02 Icu Medical, Inc. Peritoneal dialysis transfer set with antimicrobial properties
US11433215B2 (en) 2018-11-21 2022-09-06 Icu Medical, Inc. Antimicrobial device comprising a cap with ring and insert
EP4255552A1 (en) 2020-12-07 2023-10-11 ICU Medical, Inc. Peritoneal dialysis caps, systems and methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5822445B2 (en) * 1982-07-08 1983-05-09 株式会社 ミドリ十字 Method for producing stable solid human plasma cholinesterase preparation
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
JPH0296536A (en) * 1988-09-29 1990-04-09 Green Cross Corp:The Plasminogen dry formulation
DE59007142D1 (en) * 1990-01-18 1994-10-20 Cereria Amos Sgarbi Spa Grave light.
US5192743A (en) * 1992-01-16 1993-03-09 Genentech, Inc. Reconstitutable lyophilized protein formulation
SE9201073D0 (en) * 1992-04-03 1992-04-03 Kabi Pharmacia Ab PROTEIN FORMULATION
DE4239877C1 (en) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilized superoxide dismutase (SOD) composition

Also Published As

Publication number Publication date
FI952119A0 (en) 1995-05-03
TW397687B (en) 2000-07-11
IL113578A0 (en) 1995-08-31
FR2719479A1 (en) 1995-11-10
CZ286195B6 (en) 2000-02-16
HU220220B (en) 2001-11-28
PL308416A1 (en) 1995-11-13
EP0682944B1 (en) 1999-04-07
NZ272045A (en) 1996-02-27
ATE178484T1 (en) 1999-04-15
PL179240B1 (en) 2000-08-31
DK0682944T3 (en) 1999-10-18
SI0682944T1 (en) 1999-08-31
NO951724L (en) 1995-11-06
IL113578A (en) 1999-10-28
KR950031103A (en) 1995-12-18
AU694763B2 (en) 1998-07-30
JP2948125B2 (en) 1999-09-13
DE69508837T2 (en) 1999-11-04
FR2719479B1 (en) 1996-07-26
JPH0853361A (en) 1996-02-27
ES2131781T3 (en) 1999-08-01
CN1088583C (en) 2002-08-07
CA2148537C (en) 2002-07-16
DE69508837D1 (en) 1999-05-12
GR3030146T3 (en) 1999-08-31
US5763409A (en) 1998-06-09
NO320364B1 (en) 2005-11-28
CZ108195A3 (en) 1996-02-14
EP0682944A1 (en) 1995-11-22
MX9502034A (en) 1997-02-28
HU9501276D0 (en) 1995-06-28
KR100273053B1 (en) 2000-12-01
HUT72325A (en) 1996-04-29
NO951724D0 (en) 1995-05-03
ZA953596B (en) 1996-11-04
CN1116522A (en) 1996-02-14
AU1777495A (en) 1995-11-16
RU2136306C1 (en) 1999-09-10
FI117321B (en) 2006-09-15
CA2148537A1 (en) 1995-11-05

Similar Documents

Publication Publication Date Title
FI952119L (en) Stable freeze-dried formulation containing protein and test kit
FI960888L (en) Protocadherin proteins and their use
FI964311L (en) Bifunctional protein, preparation and use
FI943745L (en) Compositions and methods for protein structure determinations
BR9708400A (en) Composition, preparation and use
FI963185L (en) Hematopoietic protein and materials and methods for its preparation
FI963126L (en) Stanol mixture and its use
BR9702553A (en) Cosmetic composition and use
FI973363L (en) Composition containing nucleic acids, its preparation and use
EP0950665A4 (en) Modified physiologically active proteins and medicinal compositions containing the same
DE69712624D1 (en) SKIN TINT FORMULATION
EE9800136A (en) Pharmaceutical composition suitable for depot medicine, its preparation method and use
FI955235A0 (en) Oxazolidinedione derivatives, their preparation and use
FI951468L (en) Lipopeptide derivatives, method for their preparation and use
EE03901B1 (en) Elastic interlining and its use
FI955234L (en) Enzyme dispersions, their preparation and mixtures containing them
DE59504840D1 (en) VOLTAGE REFERENCE WITH TEST AND SELF-CALIBRATION
DE69634489D1 (en) ADENOVIRUS DODEKAHEDRIC PROTEIN COMPLEX, THIS COMPOSITION AND USES THEREOF
BR9612413A (en) Compound use of the same and pharmaceutical composition
ID21034A (en) KINASE PROTEINS AND ITS USE
FI945227L (en) Cyclic hexapeptides, their preparation and use
EE9900135A (en) N- (2-benzothiazolyl) -1-piperidinethanamine derivatives, their preparation and their use in therapy
FI952738L (en) Stable protein, phospholipid compositions and methods
FI971872A0 (en) Protein composition and its preparation and use, and preparations containing it and their preparation
FI972965A0 (en) New peptides, their preparation and use

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: SANOFI-AVENTIS

FG Patent granted

Ref document number: 117321

Country of ref document: FI

MA Patent expired